• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q3 2024

    10/23/24 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    • Record revenue of $1.6 billion
    • Record quarterly ADV of 28.3 million contracts - the second consecutive quarter of volume, open interest growth across every asset class

    CHICAGO, Oct. 23, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the third quarter of 2024.

    The company reported revenue of $1.6 billion and operating income of $1.0 billion for the third quarter of 2024. Net income was $913 million and diluted earnings per common share were $2.50. On an adjusted basis, net income was $977 million and diluted earnings per common share were $2.68. Financial results presented on an adjusted basis for the third quarter of 2024 and 2023 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

    "Q3 2024 was the best quarter in CME Group history, with records across volume, revenue, adjusted operating income, adjusted net income and adjusted earnings per share," said Terry Duffy, Chairman and Chief Executive Officer, CME Group. "This marks the second consecutive quarter of volume and open interest increases across every asset class. Our financial product volumes rose 28%, reflecting a 36% jump in interest rates to a record ADV of 14.9 million contracts. This was driven by a 35% rise in SOFR futures to a record ADV of 4.1 million contracts and 31% growth in Treasuries to a record ADV of 8.4 million contracts. In addition, our commodities volume was up 20%, options increased 27% and international ADV was a record 8.4 million contracts."

    Third-quarter 2024 ADV was a record 28.3 million contracts, including record non-U.S. ADV, with EMEA up 30% and Asia up 28% versus the same period last year.

    1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

    Clearing and transaction fees revenue for third-quarter 2024 totaled $1.3 billion. The total average rate per contract was $0.666. Market data revenue totaled $178 million for third-quarter 2024.

    As of September 30, 2024, the company had approximately $2.6 billion in cash (including $250 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the third quarter of approximately $419 million. The company has returned approximately $25.6 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

    CME Group will hold a Q&A conference call to discuss third-quarter 2024 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

    As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

    CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

    Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and order messaging traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in trade processing/post trade services (OSTTRA), our primary business and distribution partners' actions and our partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission ("SEC") on February 28, 2024, under the caption "Risk Factors".

     

    CME Group Inc. and Subsidiaries

    Consolidated Balance Sheets

    (in millions)







    September 30, 2024



    December 31, 2023

    ASSETS









    Current Assets:









    Cash and cash equivalents



    $             2,322.1



    $             2,912.0

    Marketable securities



    112.3



    111.7

    Accounts receivable, net of allowance



    629.4



    535.6

    Other current assets (includes $6.5 and $5.2 in restricted cash)



    622.0



    1,138.4

    Performance bonds and guaranty fund contributions



    99,457.0



    90,192.5

    Total current assets



    103,142.8



    94,890.2

    Property, net of accumulated depreciation and amortization



    386.2



    409.5

    Intangible assets—trading products



    17,175.3



    17,175.3

    Intangible assets—other, net



    2,892.2



    3,050.2

    Goodwill



    10,514.1



    10,495.3

    Other assets



    3,684.5



    3,685.6

    Total Assets



    $          137,795.1



    $          129,706.1

    LIABILITIES AND EQUITY









    Current Liabilities:









    Accounts payable



    $                129.9



    $                 90.6

    Short-term debt



    749.7



    —

    Other current liabilities



    485.2



    3,133.8

    Performance bonds and guaranty fund contributions



    99,457.0



    90,192.5

    Total current liabilities



    100,821.8



    93,416.9

    Long-term debt



    2,677.7



    3,425.4

    Deferred income tax liabilities, net



    5,310.0



    5,327.7

    Other liabilities



    769.4



    798.2

    Total Liabilities



    109,578.9



    102,968.2

    Total CME Group Shareholders' Equity



    28,216.2



    26,737.9

    Total Liabilities and Equity



    $          137,795.1



    $          129,706.1

     

    CME Group Inc. and Subsidiaries

    Consolidated Statements of Income

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended 

    September 30,



    Nine Months Ended 

    September 30, 





    2024



    2023



    2024



    2023

    Revenues

















    Clearing and transaction fees



    $   1,297.1



    $   1,085.5



    $  3,755.9



    $  3,404.0

    Market data and information services



    178.2



    167.6



    528.6



    496.5

    Other



    109.1



    84.7



    320.3



    239.1

    Total Revenues



    1,584.4



    1,337.8



    4,604.8



    4,139.6

    Expenses

















    Compensation and benefits



    218.8



    205.5



    629.5



    615.7

    Technology



    66.6



    55.6



    190.1



    160.2

    Professional fees and outside services



    31.0



    32.2



    98.8



    108.3

    Amortization of purchased intangibles



    55.7



    57.2



    166.4



    171.0

    Depreciation and amortization



    28.2



    31.1



    87.0



    95.3

    Licensing and other fee agreements



    97.6



    79.5



    271.4



    242.4

    Other



    62.3



    56.5



    177.2



    174.2

    Total Expenses



    560.2



    517.6



    1,620.4



    1,567.1

    Operating Income



    1,024.2



    820.2



    2,984.4



    2,572.5

    Non-Operating Income (Expense)

















    Investment income



    1,026.8



    1,272.5



    3,142.6



    4,198.4

    Interest and other borrowing costs



    (40.2)



    (39.6)



    (120.2)



    (119.7)

    Equity in net earnings of unconsolidated subsidiaries



    86.1



    76.8



    259.7



    230.1

    Other non-operating income (expense)



    (920.0)



    (1,155.6)



    (2,821.7)



    (3,733.7)

    Total Non-Operating Income (Expense)



    152.7



    154.1



    460.4



    575.1

    Income before Income Taxes



    1,176.9



    974.3



    3,444.8



    3,147.6

    Income tax provision



    264.1



    224.1



    793.6



    736.0

    Net Income



    $     912.8



    $     750.2



    $  2,651.2



    $  2,411.6

    Net Income Attributable to Common Shareholders of CME

    Group



    $     901.3



    $     740.8



    $  2,617.8



    $  2,381.3



















    Earnings per Share Attributable to Common Shareholders

    of CME Group:

















    Basic



    $       2.51



    $       2.06



    $      7.29



    $      6.63

    Diluted



    2.50



    2.06



    7.27



    6.62

    Weighted Average Number of Common Shares:

















    Basic



    359,400



    359,020



    359,329



    358,965

    Diluted



    359,989



    359,619



    359,899



    359,448

     

    CME Group Inc. and Subsidiaries

    Quarterly Operating Statistics







    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Trading Days



    63



    63



    61



    63



    64

     

    Quarterly Average Daily Volume (ADV)(1)

    CME Group ADV (in thousands)



    Product Line



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Interest rates



    10,967



    13,348



    13,839



    12,894



    14,881

    Equity indexes



    6,353



    6,922



    6,856



    6,779



    7,407

    Foreign exchange



    942



    1,007



    984



    1,075



    1,089

    Energy



    2,126



    2,158



    2,412



    2,447



    2,571

    Agricultural commodities



    1,433



    1,469



    1,596



    1,877



    1,614

    Metals



    528



    609



    675



    868



    728

    Total



    22,349



    25,513



    26,360



    25,941



    28,289

    Venue





















    CME Globex



    20,838



    23,503



    23,985



    24,143



    26,199

    Open outcry



    713



    1,126



    1,333



    825



    1,096

    Privately negotiated



    797



    885



    1,043



    974



    994

    Total



    22,349



    25,513



    26,360



    25,941



    28,289

     

    Quarterly Average Rate Per Contract (RPC)(1)

    CME Group RPC

     



    Product Line



    3Q 2023



    4Q 2023



    1Q 2024



    2Q 2024



    3Q 2024

    Interest rates



    $        0.508



    $        0.488



    $        0.486



    $        0.484



    $        0.468

    Equity indexes



    0.625



    0.616



    0.641



    0.628



    0.616

    Foreign exchange



    0.791



    0.806



    0.787



    0.754



    0.744

    Energy



    1.324



    1.338



    1.334



    1.297



    1.246

    Agricultural commodities



    1.328



    1.361



    1.356



    1.366



    1.346

    Metals



    1.492



    1.502



    1.556



    1.511



    1.540

    Average RPC



    $        0.707



    $        0.682



    $        0.695



    $        0.708



    $        0.666























    1. ADV and RPC includes futures and options on futures only.





     

    CME Group Inc. and Subsidiaries

    Reconciliation of GAAP to non-GAAP Measures

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended 

    September 30,



    Nine Months Ended 

    September 30, 





    2024



    2023



    2024



    2023

    Net Income



    $     912.8



    $     750.2



    $  2,651.2



    $  2,411.6

    Restructuring and severance(1)



    6.7



    12.6



    10.3



    14.9

    Amortization of purchased intangibles(2)



    69.3



    70.7



    206.9



    211.3

    Strategic transaction-related costs (credits)



    —



    —



    0.8



    (2.2)

    Real estate-related costs (credits)



    (1.0)



    —



    (2.0)



    —

    Foreign exchange transaction (gains) losses



    4.3



    (1.9)



    2.2



    (0.1)

    Unrealized and realized (gains) losses on investments



    —



    2.0



    (11.7)



    (71.8)

    Unrealized and realized (gains) losses on assets



    —



    —



    0.8



    0.4

    Litigation matters or settlements



    1.2



    2.0



    1.2



    2.0

    Income tax effect related to above



    (16.3)



    (17.6)



    (41.3)



    (28.6)

    Other income tax items



    —



    —



    1.9



    (0.8)

    Adjusted Net Income



    $     977.0



    $     818.0



    $  2,820.3



    $  2,536.7



















    Adjusted Net Income Attributable to Common Shareholders of

    CME Group



    $     964.7



    $     807.8



    $  2,784.8



    $  2,504.8



















    Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $       2.51



    $       2.06



    $      7.29



    $      6.63

         Diluted



    2.50



    2.06



    7.27



    6.62



















    Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $       2.68



    $       2.25



    $      7.75



    $      6.98

         Diluted



    2.68



    2.25



    7.74



    6.97



















    Weighted Average Number of Common Shares:

















         Basic



    359,400



    359,020



    359,329



    358,965

         Diluted



    359,989



    359,619



    359,899



    359,448

    Preferred shares(3)



    4,584



    4,584



    4,584



    4,584



    1. Includes $5.3 million of compensation expense due to a law change for vacation carryover in 2024.

    2. Includes $11.1 million and $33.2 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5 million and $7.5 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC in the third quarter and first nine months of 2024. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

    3. Preferred shares have similar rights as common shares without voting rights.

    CME-G

    Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-all-time-record-revenue-adjusted-operating-income-adjusted-net-income-and-adjusted-earnings-per-share-for-q3-2024-302283962.html

    SOURCE CME Group

    Get the next $CME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $CME
    Financials

    Live finance-specific insights

    See more
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

      Record revenue of $1.6 billion, up 10% from Q1 2024Record average daily volume (ADV) of 29.8 million contracts, with broad-based growth in every asset classCHICAGO, April 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the first quarter of 2025. The company reported revenue of $1.6 billion and operating income of $1.1 billion for the first quarter of 2025. Net income was $956 million and diluted earnings per common share were $2.62. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.80. Financial results presented on an adjusted basis for the first quarter of 2025 and 2024 exclude certain items, which are

      4/23/25 7:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Announces First-Quarter 2025 Earnings Release, Conference Call

      CHICAGO, March 12, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the first quarter of 2025 before the markets open on Wednesday, April 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing

      3/12/25 12:37:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    See more
    • CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

      CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

      5/9/25 10:29:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Clearing Appoints New Chief Risk Officer

      CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

      4/24/25 4:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

      Chicago , April 23, 2025 (GLOBE NEWSWIRE) -- Sterling Trading Tech (Sterling), a leading global provider of technology in order management, risk and margin, and trading, announced today the appointment of Julie Armstrong as Chief Commercial Officer, a newly created role that underscores the firm's commitment to scaling its business globally. This strategic hire signals Sterling's transition into its next phase of accelerated growth, building on recent momentum across new client segments, product innovation, asset expansion, and geographic reach. Armstrong, a recognized industry expert, brings decades of experience in global fintech strategy and revenue generation. She will lead Sterling'

      4/23/25 2:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 7:19:14 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 6:55:07 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Shepard William R bought $325,798 worth of Common Stock Class A (1,429 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      1/17/25 12:12:49 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CME Group upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

      4/8/25 9:08:11 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Raymond James with a new price target

      Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

      3/10/25 7:18:35 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group downgraded by Citigroup with a new price target

      Citigroup downgraded CME Group from Buy to Neutral and set a new price target of $250.00 from $255.00 previously

      1/6/25 7:45:08 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Sr MD Gl Hd Commodities Mkts Sammann Derek disposed of 2,175 units of Common Stock Class A, acquired 2,175 units of Common Stock Class A and sold $1,304,847 worth of Common Stock Class A (4,650 units at $280.61), decreasing direct ownership by 19% to 9,417 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      5/7/25 6:16:41 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Sr MD Gl Hd Commodities Mkts Sammann Derek was granted 3,883 units of Common Stock Class A and covered exercise/tax liability with 1,708 units of Common Stock Class A, increasing direct ownership by 23% to 11,592 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      5/7/25 5:17:16 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sammann Derek decreased direct ownership by 20% to 9,417 units (SEC Form 5)

      5 - CME GROUP INC. (0001156375) (Issuer)

      5/5/25 4:11:44 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    SEC Filings

    See more

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • CME Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CME GROUP INC. (0001156375) (Filer)

      5/9/25 1:06:49 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by CME Group Inc.

      10-Q - CME GROUP INC. (0001156375) (Filer)

      4/30/25 2:50:10 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 144 filed by CME Group Inc.

      144 - CME GROUP INC. (0001156375) (Subject)

      4/25/25 4:28:42 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

      CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

      5/9/25 10:29:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Farmer sentiment improves as long-term optimism outweighs tariff concerns

      WEST LAFAYETTE, Ind., May 6, 2025 /PRNewswire/ -- Farmer sentiment improved in April as producers expressed more optimism about current and future conditions on their farms. The Purdue University/CME Group Ag Economy Barometer rose 8 points to a reading of 148, up from 140 in March. The Index of Current Conditions climbed 9 points to 141, while the Index of Future Expectations increased 8 points to 152. The improvement in sentiment came amid ongoing tensions with many of U.S. agriculture's largest trading partners, including Mexico and Canada. Notably, a majority of producers said they believe the increased use of tariffs will ultimately benefit the U.S. agricultural economy, a view reflecte

      5/6/25 9:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/24 5:02:29 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/23 2:49:27 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/11/22 3:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance